Australia has already spent hundreds of millions over the past 36 months after raising the prices of 950 PBS medicines in 2022 to secure supply in a challenging global environment. If global pressure now forces higher prices for other medicines, so be it, but of course, it would be just another stop-gap solution for a system built on a terrible patient-loathing law.
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Australia can increase prices in response to pressure, as it did just 36 months ago for 950 medicines
December 2, 2025 - - Latest News -
CLINUVEL advances second therapy toward market with planned 2026 European filing
December 2, 2025 - - Australian Biotech -
Burnt-Out Australians rush to health appointments as year-end pressure peaks
December 2, 2025 - - Other Health -
First patient successfully dosed in TRP-8803 trial to treat binge eating disorder
December 2, 2025 - - Australian Biotech -
Immutep unveils strong Phase 2 data ahead of San Antonio breast cancer symposium
December 2, 2025 - - Australian Biotech -
New national push to close Australia’s cardiovascular data gap
December 2, 2025 - - Latest News -
US and UK strike landmark pharmaceutical deal, lifting prices
December 2, 2025 - - Latest News
